Log In
Print
BCIQ
Print
Print this Print this
 

Sonazoid, perflubutane (DD-723-B)

  Manage Alerts
Collapse Summary General Information
Company General Electric Co.
DescriptionIV perflubutane-based ultrasound contrast agent
Molecular Target
Mechanism of ActionDiagnostic; Imaging agent
Latest Stage of DevelopmentMarketed
IndicationCancer, Diagnostic
Partner

Daiichi Sankyo Co. Ltd.
 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today